Genentech Launches Direct-to-Consumer Program, Cuts Flu Vaccine Price by Nearly 70 Percent

Date:

Genentech Launches Direct-to-Consumer Program, Cuts Flu Vaccine Price by Nearly 70 Percent

The Genentech logo displayed at the company’s headquarters in San Francisco in a file photo. Justin Sullivan/Getty Images

Roche Group’s Genentech has joined the growing ranks of pharmaceutical companies selling prescription drugs directly to patients by making its Xofluza antiviral flu medicine available through online pharmacies.

Genentech’s Direct-to-Patient (DTP) program allows patients to order the single-dose vaccine from Alto Pharmacy, Amazon Pharmacy, and Mark Cuban’s Cost Plus Drugs, San Francisco-based Genentech said on Oct. 16. Patients can order the vaccine for $50, a 70-percent reduction from its list price, Genentech said.

spot_imgspot_imgspot_img

Share post:

More like this
Related

US Offers $10 Million Reward and Relocation for Information on Irans Supreme Leader, Other Top Officials

A banner depicting the Iranian regime's new leader, Ayatollah...

Trump: Iranians Face Big Hurdle in Overthrowing Regime

U.S. President Donald Trump speaks during a Women's History...

Trump Signs Executive Orders to Boost Housing Supply, Improve Access to Mortgages

Workers rebuild a home in the Eaton Fire burn...

What to Know About the Tiny Iranian Island That the US Bombed

The United States ‘obliterated’ military targets on Kharg Island...